• Aucun résultat trouvé

Biotech and bioeconomy: six of one and half a dozen of the other?

N/A
N/A
Protected

Academic year: 2022

Partager "Biotech and bioeconomy: six of one and half a dozen of the other?"

Copied!
2
0
0

Texte intégral

(1)

Proposition de papier pour le colloque SFER de juin 2019.

Biotech and bioeconomy: six of one and half a dozen of the other?

Stephane Lhuillery, Chaire de Bioeconomie Industrielle, Neoma BS.

Samih Athmane, Chaire de Bioeconomie Industrielle, Neoma BS.

Nicolas Befort, Chaire de Bioeconomie Industrielle, Neoma BS.

Important efforts are done to delineate the Bioeconomy according to a sectoral rationale (e.g. Ronzon, et al., 2017) or institutional rationale (Befort, 2019). Whereas the feasibility of a sectoral definition is questionable, a second avenue is to define the Bioeconomy according to its technologies. In this regard, the Bioeconomy is often assimilated to biotechnologies (e.g. OECD 2009). The idea is interesting because, since the 2000s, the biotechnology is now well defined by institutions (OECD, 2009) and used in a routinised way by scholars (See Lecocq and Van Looy, 2016) and thus would provide a workable definition and delineation of the Bioeconomy. Assuming that patents provide an accurate view of technological competencies, the present article evaluates the relevance of the definition comparing the technologies covered by biorefineries considered as the role model of the bioeconomy to biotechnologies covered by biotech firms.

Using USPTO and EPO data, we built the IPC code profile of a unique set of biorefineries that we compare with the OECD definition of biotech

1

. The is first step underline that biorefineries use technologies that cannot be reduced to biotechnologies. In a second step, we build the IPC code profile of French biotech firms using the French annual R&D survey in order to evaluate to what extent the non-biotech technological skills from biorefineries match the non-biotech technological skills of biotech firms following Lhuillery et al. (2006).

The article takes also the opportunity to come back on the heterogeneity of biotech chasing to compare the bioeconomy with subsamples of the biotech such as “white biotech” and “green biotech”

(Neuhäusler and Frietsch, 2013; Friedrichs, 2018). The definition of the Bioeconomy also insist explicitly or implicitly on the environmental dimension of the Bioeconomy (EU, 2018): taking stock of this dimension, we explore to what extent the Y02 class of the CPC classification (Veefkind et al., 2012). can also be a useful tool to delineate the Bioeconomy.

1 The biotechnologies is defined by OECD (2009) as technologies classified in the following IPC classes: A01H1/00,A01H4/00,A61K38/00,A61K39/00,A61K48/00,C02F3/34,C07G(11/00,13/00,15/00), C07K(4/00,14/00,16/00,17/00,19/00),C12M,C12N,C12P,C12Q,C12S,G01N27/327, G01N33/

(53*,54*,55*,57*,68,74,76,78,88,92).

(2)

Befort N (2019). Biotechnology vs Bioeconomy, Colloque de la SFER, june 4th-5th, Reims.

EU (2018) A sustainable Bioeconomy for Europe: strengthening the connection between economy, society and the environment , Updated Bioeconomy Strategy, Directorate-General for Research and Innovation, European Commission, Bruxelles.

Friedrichs S. (2018), Report on statistics and indicators of biotechnology and nanotechnology, OECD Science, Technology and Industry Working Papers 2018/06, OECD, Paris.

Lecocq C., Van Looy B. (2016) What differentiates top regions in the field of biotechnology? An empirical study of the texture characteristics of biotech regions in North America, Europe, and Asia- Pacific, Industrial and Corporate Change, 25(4) pp. 671–688.

Lhuillery S., Raffo J., Carpentier C. (2006) Using Patents for biotech statistics, Workshop on Biotechnology Outputs and Impacts, OECD Paris, December 11th, Paris

Neuhäusler, P., & Frietsch, R. (2013). Patents as indicators for knowledge generation and diffusion in mechanical engineering and green biotechnology: A first assessment (No. 34). Fraunhofer ISI Discussion Papers Innovation Systems and Policy Analysis.

Ronzon, T., Piotrowski, S., M’Barek, R., & Carus, M. (2017). A systematic approach to understanding and quantifying the EU’s bioeconomy. Bio-based and Applied Economics, 6(1), 1-17.

Van Beuzekom B., Arundel A. (2009) OECD Biotechnology Statistics, OECD, Paris.

Veefkind, V., Hurtado-Albir, J., Angelucci, S., Karachalios, K., & Thumm, N. (2012). A new EPO

classification scheme for climate change mitigation technologies. World Patent Information, 34(2),

106-111.

Références

Documents relatifs

Taking this idea seriously, we should not say that the proposition P ∨ ¬P has a classical proof but no constructive proof, but we should say that the proposition P ∨ c ¬ c P has a

Die Resultate der Studie zeigen, dass trotz einem erhöhten Risiko zu psychischen Folgen eines Einsatzes Rettungshelfer Zufriedenheit und Sinn in ihrer Arbeit finden können und

Quanti fication of epidermal DR5:GFP reflux signals (Figure 2F; see Supplemental Figure 1 online) con firmed slightly reduced basipetal re flux for twd1 (Bailly et al., 2008)

[r]

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des

Based on this dataset, we explored the openness of each article, if it has been published in a gold or hybrid OA journal or if it is legally available on an

O novo enigma da indução, como vimos, colocou uma dificuldade grave para o projeto de Hempel de definir a relação de confirmação, o qual Goodman enxerga como sendo essencialmente

Une troisième bioéconomie – qui apparaît aujourd’hui dominante dans les discours officiels – correspond à une économie exploitant les différentes formes de biomasse et son